Publikacje

.

Farmacja III rok

Koło

2013

1. Nieborowska-Skorska M, Hoser G, Hochhaus A, Stokłosa T, Skorski T. Anti-oxidant vitamin E prevents accumulation of imatinib-resistant BCR-ABL1 kinase mutations in CML-CP xenografts in NSG mice. Leukemia. 2013 Apr 22. doi: 10.1038/leu.2013.123. [Epub ahead of print]

2012

1. Klionsky D., Gołąb J., oraz wielu innych, Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy, 2012; 8(4): 445-544

2. Garg A., Krysko D., Werfaille T., Kaczmarek A., Ferreira G., Marysael T., Rubio N, Firczuk M., Mathieu C., Roebroek A., Annaert W., Gołąb J., Witte de P., Vandenabeele P., Agostinis P., A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. Embo Journal, 2012; 31(5): 1062-1079

2011

1. Virgili A, Koptyra M, Dasgupta Y, Głodkowska-Mrówka E, Stokłosa T. Nacheva EP, Skorski T. Imatinib sensitivity in BCR-ABL 1-positive chronic myeloid leukemia cells in regulated by the remaining normal ABL 1 allele. Cancer Res. 2011; 71(16): 5381-6

2. Koptyra M, Stokłosa T, Hoser G, Głodkowska-Mrówka E, Seferyńska I, Klejman A, Błasiak J, Skorski T. Monobiquitinated Fanconi anemia D2 (FANCD2-Ub) is required for BCR-ABL 1 kinase-induced leukemogenesis. Leukemia. 2011; 25(8): 1259-67

2010

1. Marek Jakóbisiak, Jakub Gołąb: Statins can modulate effectiveness of antitumor therapeutic modalities. Medicinal Research Reviews, 2010; 30 (1): 102-135.

2. Jacek Bil, Łukasz Zapała, Dominika Nowis, Marek Jakóbisiak, Jakub Gołąb: Statins potentiate cytostatic/cytotoxic activity of sorafenib but not sunitinib against tumor celllines in vitro. Cancer Letters: 2010; 288(1): 57-67.

2009

1. Urszula Mackiewicz, Michał Maczewski, Anna Konior, Jamaes O. Tellez, Dominika Nowis, Halina Dobrzyńska, Mark R. Boyett, Bohdan Lewartowski.: Sarcolemmal Ca2+ ATPase ability to transport Ca2+ gradually diminishes after myocardial infarction in the rat. Cardiovascular Research; 2009;  81: 546-554.

2008

1. Mrówka P., Głodkowska E., Nowis D., Legat M., Issat T., Makowski M., Szokalska A., Janowska S., Stokłosa T., Jakóbisiak M., Gołąb J.: Ciglitazone, an agonist of peroxisome proliferator-activated receptor gamma, exerts potentiated cytostatic/cytotoxic effects against tumor cells when combined with lovastatin. International Journal of Oncology; 2008; 32: 249-255

2007

1. Rink L, Slupianek A, Stoklosa T, Nieborowska-Skorska M, Urbanska K, Seferynska I, Reiss K, Skorski T. Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex RAD50-Mre11-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells. Blood. 2007 Apr 12; [Epub ahead of print]

Strony